Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
2025
1 citations
erratum
hybrid Open Access
Field-Weighted Citation Impact:
1.82
·
University of California, Los Angeles
Mariza Daras
·
University of California, San Francisco
Timothy F. Cloughesy
·
University of California, Los Angeles
Howard Colman
·
University of Utah
Priya Kumthekar
·
Northwestern University
Clark C. Chen
·
University of Minnesota
Robert Aiken
·
Rutgers, The State University of New Jersey
Morris D. Groves
·
Texas Oncology
Shirley Ong
·
The Ohio State University Wexner Medical Center
Rohan Ramakrishna
·
NewYork–Presbyterian Hospital
Michael A. Vogelbaum
·
Moffitt Cancer Center
Simon Khagi
·
University of North Carolina at Chapel Hill
Thomas Kaley
·
Memorial Sloan Kettering Cancer Center
Jason M. Melear
·
Baylor University Medical Center
David M. Peereboom
·
Cleveland Clinic
Analiz Rodriguez
·
University of Arkansas for Medical Sciences
Maxim Yankelevich
·
University of Michigan
Suresh Nair
·
Lehigh Valley Hospital-Pocono
Vinay K. Puduvalli
·
The University of Texas MD Anderson Cancer Center
Kenneth Aldape
·
National Cancer Institute
Andrew Gao
·
University Health Network
Álvaro López‐Janeiro
·
Navarre Institute of Health Research
Carlos E. de Andrea
·
Navarre Institute of Health Research
Marta M. Alonso
·
Navarre Institute of Health Research
Paul C. Boutros
·
University of California, Los Angeles
Joan M. Robbins
·
Lineage Cell Therapeutics (United States)
Warren Mason
·
University Health Network
Adam M. Sonabend
·
Northwestern University
Roger Stupp
·
Northwestern University
Juàn Fueyo
·
The University of Texas MD Anderson Cancer Center
Candelaria Gomez‐Manzano
·
The University of Texas MD Anderson Cancer Center
Frederick F. Lang
·
The University of Texas MD Anderson Cancer Center
Gelareh Zadeh
·
University of Toronto
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial | Researchclopedia